Table 1.
Demographic and baseline clinical characteristics of the treated population.
| Male | Female | Overall | |
|---|---|---|---|
| Number of patients, n (%) | 20 (36) | 35 (64) | 55 |
| Age in years, mean ± SD | 53.3 ± 9.9 | 53.9 ± 11.7 | 53.7 ± 11.0 |
| Chronic rhinosinusitis with nasal polyps (CRSwNP), yes, n (%) | 20 (100) | 35 (100) | 55 (100) |
| Endoscopic sinus surgery (ESS), yes, n (%) | 11 (55) | 19 (54) | 30 (55) |
| Endoscopic sinus surgery (ESS), median (IQR) | 1 (0;2) | 1 (0;2.8) | 1 (0;2) |
| Asthma, yes, n (%) | 17 (85) | 32 (91) | 49 (89) |
| Respiratory disease exacerbated by aspirin and nonsteroidal anti-inflammatory drugs (AERD), yes, n (%) | 11 (55) | 17 (49) | 28 (51) |
| Smoker, yes, n (%) | 5 (25) | 4 (11) | 9 (16) |
| Allergic, yes, n (%) | 10 (50) | 19 (54) | 29 (53) |
| Corticosteroid dependent, yes, n (%) | 15 (75) | 29 (83) | 44 (80) |
| Lund-Mackay score, median (IQR) | 20 (19;2) | 20 (13;23) | 20 (16;22) |
Data are means ± SD when normality is assumed; medians (IQR) under non-normality and frequencies (%). SD: standard deviation; IQR: interquartile range.